Delivery Order SPE2DB20D3101-SPE2DB22FQTK7

Award Date 8/31/22
Potential Completion Date 9/1/22
Potential Value $38K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,792.74 firm-fixed-price delivery order is for the supply of Vemlidy 25 mg tablets to support military healthcare needs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,928.44 delivery order is for the supply of Vemlidy 25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,957.98 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The $34,970.40 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for the delivery of Vemlidy 25mg tablets. The award, valued at $9,341.62, was made by the Defense Logistics Agency (DLA) Troop Support Medical on August 9, 2023, with a completion date of September 6, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The contract has a ceiling value of $3,766.21 and a period of performance through April 12, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has extensive experience providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,568.67 firm-fixed-price delivery order is for the medication Vemlidy 25 mg tablet, with an ultimate completion date of February 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $17,284.07, is for the delivery of Vemlidy 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2023. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,225.21 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award, valued at $12,304.50, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract is for the delivery order of 4,565,363,760 units of the prescription medication Vemlidy 25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FQTK7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $38,351.04 firm-fixed-price delivery order is for the pharmaceutical product Vemlidy 25 mg Tablet, with a completion date of September 1, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this particular award, indicating open competition. This contract demonstrates AmerisourceBergen's role as a critical pharmaceutical distributor for the U.S. Department of Defense, providing essential medications and medical commodities.

Generated 2/27/25, 10:29 AM